OTCPicks.com

For Tuesday, July 8th

CELI, MGRN, LLSR, BSRC, XSNX
XKEM, UDTT, FMNJ, GGLB, UOMO, ARTE, ALTI, ADAT

Our Stocks to Watch today include CelebDirect (OTC: CELI), Monogram Energy Inc. (OTC: MGRN), Lantis Laser Inc. (OTC: LLSR), BioSolar Inc. (OTCBB: BSRC), XsunX Inc. (OTCBB: XSNX), Xechem International Inc. (OTC: XKEM), Universal Detection Technology (OTCBB: UDTT), Franklin Mining Inc. (OTC: FMNJ), Green Globe International Inc. (OTCBB: GGLB), UOMO Media Inc. (OTCBB: UOMO), Artes Medical Inc. (NASDAQ: ARTE), Altair Nanotechnologies Inc. (NASDAQ: ALTI) and Authentidate Holding Corp. (NASDAQ: ADAT).

FEATURED COMPANY

QMCI

CELEBDIRECT INCORPORATED (OTC: CELI)

Detailed Quote: http://www.otcpicks.com/quotes/CELI.php

Company Profile: http://www.otcpicks.com/celebdirect/celebdirect-2.htm

CelebDirect's primary business is that of a direct response celebrity incubator and has two divisions which are direct response marketing and Celebrity placement / franchise opportunities. CelebDirect brings to the market unique and innovative products via direct to market strategies such as infomercials, advertorials and other associated advertising vehicles to expeditiously, economically and broadly market products throughout North American as well as a global basis. CelebDirect has a number of consumer oriented products it is evaluating and others it is currently bringing to market.

CELI News:

July 8 - CelebDirect and the Muscle Flex™ Step into the Mixed Martial Arts Octagon to Rollout the First Stage of the Muscle Flex™ Marketing Strategy in Print and Online Media

CelebDirect and the Muscle Flex™ Step into the Mixed Martial Arts Octagon to Rollout the First Stage of the Muscle Flex™ Marketing Strategy in Print and Online Media

CelebDirect (OTC: CELI) has begun the first phase of its Direct Response marketing strategy for the Muscle Flex™ (www.MuscleFlex.tv) in a number of Martial Arts and Mixed Martial Arts publications and online websites. These full and half page ads are part of a 1-year campaign designed to create and escalate awareness and sales as we expand our marketing campaign into television in 1 and 2 minute short form and 30 minute infomercial spots. The magazines include:

Mixed Martial Arts Magazines

* Black Belt Magazine
* Fight! Magazine
* MMA Authority
* Ultimate Grappler
* Inside Kung Fu
* Tapout Magazine
* MMA Worldwide

Mixed Martial Arts Websites

* www.MMAWeekly.com
* www.MMANews.com
* www.BlackBeltMag.com
* www.Sherdog.com

The Muscle Flex(TM) is ideal for the Martial Arts and anyone who is trying to develop strength, flexibility and improve their fitness level. Its "one-of-a-kind gliding" motion is revolutionary in how it delivers results and fitness benefits.

"The print and online advertising are the beginning phases before we rollout our comprehensive North American wide television campaigns," commented Danny Alex, CEO of CelebDirect. "We are expecting the Muscle Flex 30 minute infomercial to be one of the most successful infomercials of its kind."

Go to www.MuscleFlex.tv to learn about the Muscle Flex and why we describe it as a revolution in the Fitness Industry. A wealth of pictures, video and detailed text provides consumers a comprehensive and entertaining venue for The Muscle Flex(TM).

It's the only machine of its kind that delivers strength, flexibility and cardio training all in one fluid motion. It also improves posture, sculpts and tones, and develops long lean toned muscles. The most popular fitness phenomenon is creating long, lean muscles by combining toning and stretching against resistance. With the population of America rapidly aging, body toning and stretching will undoubtedly be the next "fitness craze."


FEATURED COMPANY

QMCI

MONOGRAM ENERGY INCORPORATED (OTC: MGRN)
"Up 25.00% in morning trading"

Detailed Quote: www.otcpicks.com/quotes/MGRN.php

Company Profile:
www.otcpicks.com/monogram-energy/monogram-energy.htm

Monogram Energy, Inc. is an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties. The company specializes in acquiring oil & gas leases with proven reserves that have the potential for increased production.

MGRN News:

July 7 - Monogram Energy Inc. to Post Financials

Monogram Energy, Inc. (OTC: MGRN), an independent energy company engaged in the acquisition, development, and exploitation of oil and gas properties, announced that it has completed its issuer services agreement with Pink OTC Markets Inc. (formerly Pink Sheets). This action allows Monogram to provide current disclosure to the marketplace.

Monogram is presently working on current unaudited financial statements, and intends to post them on Pink Sheets' website as soon as they are completed. Mr. Billy King, Chief Executive Officer of Monogram Energy, Inc., stated, "Posting our financials gives us the mechanism to become more fully transparent to the investing public, and provides our shareholders another avenue to keep abreast of our progress."

Mr. King became interested in the production of oil & gas during his ten years of employment as an attorney for the Halliburton Company, and with his representation of independent oil companies during his years as a private practitioner. Monogram Energy's goal is to maintain a high risk/reward profile, thereby enabling them to return the most value to its shareholders.


FEATURED COMPANY

QMCI

LANTIS LASER INCORPORATED (OTC: LLSR)

Detailed Quote: http://www.otcpicks.com/quotes/LLSR.php

Company Profile: http://www.otcpicks.com/lantis-laser/lantis-laser-2.htm

Lantis Laser was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System™ in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); LightLab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser, visit www.lantislaser.com.

LLSR News:

July 8 - Lantis Laser's OCT Dental Imaging System Will Drive the New Era of Minimally Invasive Dentistry

From Lantis Laser, Inc. (OTC: LLSR): Fluoride and its protection against tooth decay are well documented. Its action is best on the smooth surfaces of teeth. So, what about all those pits and fissures on the biting surface where decay is most prevalent? Recently, a new generation of topical products has been developed that have the ability to remineralize enamel from the bottom up, therefore reversing that dreaded decay, but only when detected very early on.

The list of products that can be used to arrest or reverse the decay process include amorphous calcium phosphate, fluoride varnishes, fluoride rinses and disinfecting mouth rinses. For the successful implementation of these treatments, early detection of decay is essential but is difficult with present day dental diagnostics as no imaging modalities provide the level of resolution required for early detection so that minimally invasive treatment with topical products can be prescribed. This is a barrier to the wider adoption of Minimally Invasive Dentistry (MID) and the dental profession is fully aware of this.

According to Dr. Craig Gimbel, Executive Vice President of Clinical Affairs for Lantis Laser, Inc, "The introduction of Lantis' Optical Coherence Tomography (OCT) Dental Imaging System in the first quarter of 2009 will enable dentists to non-invasively image what they never were able to do before - the microstructure of teeth at a high resolution to detect early decay, using just light."

Dr. Gimbel continued, "Even x-rays are not capable of imaging early decay in those tiny pits and fissures. OCT will drive a new generation of MID and every dental office will require an OCT System to diagnose and treat very early decay." Dr Gimbel points out "both the dentist and the patients they treat can only benefit. Early diagnosis means possibly you may avoid that dreaded dental drill."

Research studies have shown that OCT technology can provide evidence for early decay demineralization and then follow the process of remineralizing, all without the risk of radiation.

Lantis' OCT Dental Imaging System is based on novel light-based, bio-medical imaging technology, Optical Coherence Tomography, that enables the dentist to do diagnostic imaging, chairside and in real-time. As the power source is light-based, unlike x-ray there is no harmful radiation. Images can be captured at a resolution of up to 10 times that of x-ray, enabling early detection of decay and detailed examination of microstructural defects.


FEATURED COMPANY

QMCI

BIOSOLAR INCORPORATED (OTC: BSRC)
"Up 7.60% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php

Company Profile: http://www.otcpicks.com/biosolar/biosolar-2.htm

BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.

BSRC News:

July 7 - Record-High Petroleum Prices a Boon to BioSolar

Company's Cost-Saving Bio-Based Materials for Photovoltaic Solar Modules Poised to Decrease Industry's Oil Dependence

BioSolar, Inc. (OTCBB: BSRC) reports that surging oil prices have resulted in unprecedented price hikes in photovoltaic solar module manufacturing, creating substantial growth opportunities for BioSolar. The company’s breakthrough technology dramatically reduces the cost of solar modules by replacing traditional and expensive petroleum-based components with bio-based materials derived from renewable plant sources. This dramatic pricing differential is expected to accelerate demand for BioSolar’s products as manufacturers scramble to control skyrocketing manufacturing and components costs.

“With the plastics industry undergoing price increases of up to 40% for petroleum-based plastics, we believe that the cost savings offered by our BioBacksheet™ product will accelerate manufacturers’ adoption of our product into their photovoltaic modules,” said Dr. David Lee, BioSolar’s CEO. “The savings will reduce the final cost per watt of solar electricity by allowing manufacturers to lower the cost of their finished product without being impacted by the rising cost of petroleum.”

A recent article in PlasticsNews underscores how manufacturers are impacted by price increases of commodity chemicals, as well as "almost unprecedented" run-ups in energy and raw materials costs. The June 22, 2008 article notes that companies are impacted not only by rising raw materials costs, but the associated electricity and transportation costs as well. Kevin Swift, chief economist at the American Chemistry Council, says, "Each $1 increase in the price of a barrel of crude oil costs the chemical industry $660 million annually …For a $1 increase in 1 million BTUs of natural gas, it's $3.3 billion in new costs."

“The market for solar power is already in explosive growth mode, and photovoltaic technology has progressed markedly in recent years with advances making the cells more efficient, lighter and less expensive. But BioSolar is singularly positioned to lead the development of truly sustainable and cost-effective solar technology as the first company to introduce a new dimension of cost reduction by replacing petroleum-based plastic solar cell module components with durable non-food, bio-based materials,” said Lee.

BioSolar is in the process of transitioning into full-scale production of its BioBacksheet™ in a 60,000-square-foot state-of-the-art facility operated by its contract manufacturing partner, Rowland Technologies, Inc.

By incorporating Rowland Technologies’ world-class manufacturing capabilities with BioSolar’s unique material engineering, BioSolar is producing an environmentally-friendly product with characteristics that exceed the thermal index requirements of solar module manufacturers.

“We expect this breakthrough product to be rapidly accepted as the standard for the backsheet component of both traditional and certain thin-film photovoltaic modules,” said Lee.


FEATURED COMPANY

IMAGE

XSUNX INCORPORATED (OTCBB: XSNX)

Detailed Quote: http://www.otcpicks.com/quotes/XSNX.php

Company Profile: http://www.otcpicks.com/xsunx/xsunx.htm

Xsunx, Inc., a thin-film photovoltaic (TFPV) company, focuses on developing thin film photovoltaic (TFPV) amorphous silicon solar cell manufacturing processes to produce TFPV solar modules. Its product includes XsunX ASI-120 module, which is a 125 peak watt TFPV solar module utilizing glass substrates and a proprietary semiconductor manufacturing system. XsunX ASI-120 provides for a module delivering high power output, and size and framing that would allow for the use of various existing mounting systems. The target markets for the TFPV solar module include solar farms, government agencies, and utility companies, as well as power purchase agreements and large commercial installations worldwide. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is headquartered in Aliso Viejo, California.

XSNX News:

July 8 - XsunX, Inc. Announces Upcoming Shareholder Conference Call

XsunX Inc. (OTCBB: XSNX), a solar technology company engaged in the build-out of its multi-megawatt thin film photovoltaic (TFPV) solar manufacturing facilities, announced the scheduling of an open line Q&A conference call on Thursday, July 10, 2008 from 1-2 p.m. Pacific (4-5 p.m. Eastern) for the investment community to call in and discuss with XsunX executive management the topics of the shareholder letter released June 24, 2008 — including the company's efforts to establish its TFPV manufacturing presence.

Conference Call

To participate in the call, please dial in to the toll free number, up to fifteen minutes prior to the scheduled start time.

The dial-in number is 1-866-394-7480, conference ID number: 54867296

For more information about XsunX and to view the shareholder letter, visit www.xsunx.com.


STOCKS TO WATCH

XECHEM INTERNATIONAL INCORPORATED (OTC: XKEM)
"Up 110.53% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/XKEM.php

Xechem International is a development stage biopharmaceutical company working on Sickle Cell Disease (SCD). Its recent focus and resources have been directed primarily toward the development and launch of NICOSAN™. In addition to NICOSAN™, Xechem is also working on another sickle cell compound, 5-HMF, which it has licensed from Virginia Commonwealth University.

XKEM News:

July 3 - Xechem International Announces Conference Call to Address Information Update

Xechem International (OTC: XKEM) announced that it will be holding a conference call to update shareholders and other interested persons on its business operations and financial status. Details regarding the call are:

Date: July 10, 2008
To: 9:30 a.m. Central Daylight Time
Dial-In: Domestic: 1-866-548-2692
International (outside the U.S. & Canada): 904-596-2360


UNIVERSAL DETECTION TECHNOLOGY (OTCBB: UDTT)
"Up 33.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/UDTT.php

Universal Detection Technology engages in the research and development of bioterrorism detection devices in the United States. It principally designs, manufactures, markets, and sells automated continuous air monitoring instruments used to detect and measure various types of air pollution, such as acid rain, ozone depletion, and smog episodes. The company primarily offers the BSM-2000 device, an automated real-time bacterial spore detector, used for detection of abnormal levels of airborne endospores, such as anthrax. BSM-2000 is designed to provide unattended monitoring of airborne bacterial spores in public places, with real-time automated alert functionality. Universal Detection Technology also offers anthrax detection test kits, surveillance cameras, anti-microbial products, and training material and references DVDs. The company, formerly known as Pollution Research and Control Corporation, was founded in 1971. Universal Detection Technology is headquartered in Beverly Hills, California.

UDTT News:

July 8 - Universal Detection Technology Receives Contract to Provide Radiation Detection Equipment for the 2008 Beijing Olympics

Universal Detection Technology (OTCBB: UDTT) (Frankfurt: PO8.F), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported that it has received a contract to provide radiation detection equipment for the 2008 Beijing Olympics. The devices are capable of detecting Gamma and Neutron Radiation and are designed to provide portal protection.

The Beijing Organizing Committee for the Games of the XXIX Olympiad (BOCOG) is responsible for all aspects of security for the Olympics. BOCOG plans to deploy 80,000 security personnel for the Olympics. According to Liu Shaowu, the BOCOG security department director, ``BOCOG has finished more than 52 schemes and more than 500 specific plans for security, transportation, fire-fighting, anti-terrorism and VIP protection. Beijing will host safe Games.''

UDTT will supply equipment that will be used for search and identification of gamma and neutron radioactive materials. The instruments feature the capability to identify the detected isotopes and characterize categories from medical, industrial, natural occurring radioactive materials (NORM) and special nuclear materials (SNM). Because of their high sensitivity, they can be used to verify any alarm triggered by a fix-installed monitor or by a radiation pager, to locate sources, measure radiation levels, and even to identify the detected isotope. The instruments are ideally suited for First Responders, Border Control, Customs inspectors, site security in critical infrastructures, and for all missions related to the control of nuclear materials.

When used in concert, the instruments are optimal in providing portal protection for entrances to venues such as sports stadiums and the Olympic village. The device characteristics include:

* Gamma & neutron independent channels
* Very high sensitivity, fast response
* Relative thresholds to background
* Real time rejection of sudden background variation (VBS algorithm)
* Automated spectra acquisition on alert and identification (NMD algorithm)
* Clear discrimination of risk category
* Visual and audible alarms
* Wireless communication interface
* Designed to meet / exceeds ITRAP and ANSI standards

“The contract for the Beijing Olympics is another significant milestone for our company,” said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. “We will continue to pursue clients of this caliber and prestige with our full spectrum of CBRNE detection equipment,” he added.

The contract to supply UDTT's radiation detection equipment for the 2008 Beijing Olympics has come from F&D International Corporation. For more information, visit http://www.udetection.com or e-mail This email address is being protected from spam bots, you need Javascript enabled to view it .


FRANKLIN MINING INCORPORATED (OTC: FMNJ)
"Up 15.79% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/FMNJ.php

Franklin Mining, Inc. primarily has mining and energy interests in the United States and Bolivia. It also holds various energy interests for the development and construction of gas-to-liquid facilities in Argentina. Franklin Mining, Inc. was formerly known was WCM Capital, Inc. The company was founded in 1864 and is headquartered in San Antonio, Texas with additional offices in La Paz and Santa Cruz, Bolivia and Buenos Aires, Argentina.

FMNJ News:

July 8 - Franklin Expands US Energy Subsidiary and Establishes Franklin Mining Colombia LTDA

Franklin Oil & Gas, Inc. Set to Enter West Texas Oil Field

Franklin Mining, Inc. (OTC: FMNJ) (Frankfurt: FMJ.F) Chairman and President, William A. Petty, announces that ongoing negotiations for US energy projects have resulted in a significant change in previously announced plans for the company's US energy division. Franklin Mining, Inc. has retained full ownership of the recently formed subsidiary, Franklin Oil & Gas, Inc., and is prepared to begin work in west Texas.

Mr. Petty also announced that incorporation documents have been prepared for formation of Franklin Mining Colombia LTDA and all requested information has been submitted to ECOPETROL (Colombia's national oil company) to register future crude oil sales.


GREEN GLOBE INTERNATIONAL (OTCBB: GGLB)
"Up 9.38% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GGLB.php

Green Globe International, Inc., through its subsidiaries, engages in the travel, tourism, and related green businesses worldwide. The company offers Voyager Network travel distribution platform providing direct access to reservation systems of various travel suppliers, including airlines, cruise lines, hotels, car rental companies, and providers of other travel amenities worldwide. It searches for availability and price for the itinerary suggested by the buyer over various direct connected suppliers and global distribution systems; and presents the aggregated result in the format preferred by the buyer. The company, formerly known as GTREX Capital, Inc., was incorporated in 1999 and is based in Murrieta, California.

GGLB News:

July 7 - Green Globe International, Inc. Announces Initial Agreement With PA Consulting Group for Collaboration on Sustainability Projects

Initial Focus Expected to Be Sustainability and Carbon Neutrality Programs for Caribbean Nations

Green Globe International, Inc. (OTCBB: GGLB), which owns the Green Globe brand, the premier international green brand focused on sustainability and carbon neutrality programs, announced that it has entered into an initial agreement in the form of a Memorandum of Understanding with PA Consulting Group, a leading global management consultancy company. Green Globe International and PA Consulting Group plan to cooperate in several specified areas related to the delivery of sustainability programs under the Green Globe banner.

Under terms of the MOU, the areas of collaboration between PA Consulting Group and Green Globe International, Inc., include, but are not limited to: 1) identify potential tourism destinations (e.g., countries, territories, municipalities, and resort areas) for Green Globe International programs; 2) secure the support and participation of key stakeholders in the destination; 3) design and develop a destination-specific Sustainability and Carbon Neutrality Plan; 4) work with Green Globe International to secure funds to finance the implementation of the Sustainability and Carbon Neutrality Plan; 5) manage the implementation of the Sustainability and Carbon Neutrality Plan; 6) monitor and report progress toward key sustainability and carbon generation indicators for Energy consumption; Waste production; Water usage; Chemical usage; Community Engagement, and local economic benefit; 6) certify that communities and businesses are compliant with the Green Globe Benchmarking and Certification Programs available; and 7) provide an annual review to confirm compliance with Benchmarking Standards which qualify for Certification.

After meetings with Caribbean tourism organizations and officials, Green Globe International recently announced plans to deliver sustainability and carbon neutrality solutions for the region. Green Globe International will further seek to expand these programs to countries and destinations worldwide.

Steven R. Peacock, chief executive officer and managing director of Green Globe International, Inc., commented, "We are extremely pleased to have established a relationship with PA Consulting Group and believe that they will be a tremendous partner for Green Globe and will assist greatly in the implementation of our sustainability programs.

"The support of PA Consulting Group is expected to contribute significantly to the success of the Green Globe program, particularly as we seek to expand the awareness of our Sustainability and Carbon Neutrality Plans for destinations and countries that are concerned with the quality of their environment. As this agreement details, we also anticipate that PA will play an integral role in the implementation of Green Globe programs to the participating destinations and countries."

According to Bill Meade, Partner with PA Consulting Group, "Green Globe has provided a roadmap for governments, companies, and communities interested in applying environmental and social sustainability programs to the tourism sector."

PA has helped over 50 hotels, resorts and tourism attractions become Green Globe benchmarked and certified, and three tourism destinations become Green Globe benchmarked. PA was instrumental in introducing Green Globe to Caribbean and Middle East tourism markets, including helping the first four hotels in the world, all from Jamaica, become Green Globe certified.

"We are excited about the inclusion of carbon neutrality to the Green Globe program as the global tourism industry, host country governments, and private businesses are seeking to reduce their 'carbon footprint' and participate in international carbon trading and financing schemes," Mr. Meade added.

The World Travel and Tourism Council (WTTC) established Green Globe in 1992 as a response to the United Nations Rio de Janeiro Earth Summit, where 182 Heads of State endorsed the Agenda 21 principles of Sustainable Development. Green Globe is the only international sustainability program based on Agenda 21 principles.

Green Globe International (www.greenglobeint.com) encourages all shareholders and others interested in following the progress of the company to subscribe to receive email alerts whenever new information is made public. To subscribe, visit www.greenglobeint.com/stayconnected/email.

ABOUT PA CONSULTING GROUP

PA Consulting Group is an independent, employee-owned, global firm of 3,000 talented individuals, operating from offices across the world, in Europe, North America, Latin America, Asia, and Oceania. PA has won numerous awards for delivering complex and highly innovative assignments, run one of the most successful venture programmes in the consulting industry, technology development capability that few firms can match, deep expertise across key industries and government, and a unique breadth of skills from strategy to IT to HR to applied technology. PA has earned a worldwide reputation for transforming the performance of organizations.

Green Globe Benchmarking and Certification

Brisbane-based EC3 Global, a leading international environmental and tourism advisory group, is wholly owned by the Sustainable Tourism Cooperative Research Centre (STCRC), the world's largest tourism research organization. As the commercialization company for STCRC's intellectual property, EC3 Global is the exclusive provider of the Green Globe benchmarking and certification program worldwide. For additional information on EC3 Global, visit www.ec3global.com.


UOMO MEDIA INCORPORATED (OTCBB: UOMO)
"Up 9.47% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/UOMO.php

UOMO Media Inc. is a multi-channel entertainment company that acquires, produces, and manages intellectual media content and digital assets. UOMO integrates existing and well-established revenue streams in recorded music, publishing, talent management and distribution through its four operating divisions: UOMO Digital Distribution, UOMO Recorded Music, UOMO Talent Management, and UOMO Publishing.

UOMO News:

July 8 - UOMO Media Announces Revenues

UOMO Media Inc. (OTCBB: UOMO), a multi-channel entertainment and media company, announced that in the first two months of the first quarter of the new fiscal year, the company has experienced (unaudited) revenues.

The company noted that while there has been an economic downturn of late, the numbers would seem to point to a turn-around when it comes to the opportunity of monetizing entertainment assets. The International Federation of the Phonographic Industry (IFPI) estimated that the broader music industry was worth approximately US$130 billion in 2006.

PriceWaterhouseCoopers estimates that by 2011, the global media and entertainment industry will be worth US$ 2 trillion.

The Company’s CFO, Ms. Jueane Thiessen commented, “The revenues from the launch of our new operations have exceeded management’s internal expectations and our numbers seem to demonstrate that we are moving into revenues faster than we originally anticipated.”

Mr. Camara Alford, CEO and Chairman of UOMO Media, added, "This further confirms our business model. With our vision of how we can develop the current market opportunities, we expect that we will only continue to increase our revenues across our entertainment-based media properties.”

The company notes that the numbers contained in this release are unaudited, and are made in good faith and based on all the financial information available to the company at present.


ARTES MEDICAL INCORPORATED (NASDAQ: ARTE)
"Up 26.09% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ARTE.php

Artes Medical, Inc., a medical technology company, focuses on the developing, manufacturing, and commercializing injectable aesthetic products for the dermatology and plastic surgery markets in the United States. It offers ArteFill, a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds. The company also provides individual skin test kits. Artes Medical markets and sells ArteFill to dermatologists, plastic surgeons, and cosmetic surgeons through its direct sales force. The company, formerly Artes Medical USA, Inc., was founded in 1999 and is headquartered in San Diego, California.

ARTE News:

July 8 - Artes Medical Broadens Product Portfolio Through Exclusive U.S. Sales and Marketing Agreement for Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler

Artes Medical, Inc. (NASDAQ: ARTE), a medical aesthetics company, announced that it has entered into an exclusive U.S. sales and marketing agreement with Anika Therapeutics Inc. (NASDAQ: ANIK) for Elevess, Anika’s proprietary FDA-approved hyaluronic acid (HA) based temporary dermal filler for the correction of facial wrinkles and folds.

Through this agreement, Artes Medical’s dedicated sales force will market and sell Elevess, the first FDA-approved HA dermal filler for the temporary correction of facial wrinkles that is formulated with an anesthetic for patient comfort, as well as the company’s flagship product, ArteFill, the first and only FDA-approved non-resorbable wrinkle filler for long-lasting correction of smile line wrinkles. As a result, Artes Medical becomes the first and only company in the U.S. with a product portfolio of approved dermal fillers that provide patients with a full range of treatment options.

“Through our agreement with Anika Therapeutics we have broadened our product portfolio for our 42-person sales team enabling us to now provide physicians and patients with more treatment options for wrinkle correction,” said Christopher J. Reinhard, Executive Chairman, Artes Medical. “Elevess is ideal for patients seeking immediate, comfortable wrinkle correction that lasts six months or more, and ArteFill is the only FDA-approved, non-resorbable treatment for patients desiring long-lasting results. Both products are excellent stand-alone treatment options for wrinkle correction. In addition, they may also be bundled for sequential use. Elevess may be used for initial correction during the ArteFill skin test waiting period, to be followed by an ArteFill long-lasting treatment. Based on this, we will be introducing a new plan that provides favorable economic incentives for both physicians and patients when ArteFill and Elevess are used in concert with each other. With these products, Artes Medical is now uniquely positioned to deliver a full spectrum of wrinkle treatments for the growing facial aesthetics market.”

Under the terms of the agreement, Anika Therapeutics will manufacture Elevess and supply Artes Medical with a fully packaged product. Artes Medical will be responsible for the marketing and sale of Elevess to dermatologists, plastic surgeons and cosmetic surgeons in the U.S.

ABOUT ELEVESS

Anika’s Elevess is the first FDA approved injectable soft-tissue filler to combine hyaluronic acid (HA) and lidocaine, a local anesthetic that improves patient comfort, and provides physicians with a new alternative for their aesthetic practice. Hyaluronic acid is a naturally occurring polymer found throughout the body and is present in the skin, where it supports skin structure and elasticity. Designed for longer durability based on its proprietary cross-linking technology and its high concentration of Anika’s chemically modified hyaluronic acid, Elevess has been approved for sale in the United States, the European Union and Canada.

ABOUT ARTEFILL

ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles known as smile lines or nasolabial folds. The unique PMMA microspheres in ArteFill are not absorbed by the body and therefore provide the first-of-its-kind support for long-lasting wrinkle correction.

An ArteFill Skin Test is required before initial treatment. The most common adverse events associated with ArteFill treatment, similar to those observed with other dermal fillers, are lumpiness, persistent swelling or redness and increased sensitivity at the injection site.

ArteFill is a proprietary formulation comprised of polymethylmethacrylate, or PMMA, microspheres and bovine collagen, and is the only PMMA-based injectable product that has been approved by the FDA for the treatment of facial wrinkles. Artes Medical is the sole manufacturer of ArteFill, which is only available in the United States through Artes Medical, and Artes Medical has not entered into distribution or licensing arrangements with any third party for the distribution or sale of ArteFill, or any other PMMA-based dermal filler, outside the United States.


ALTAIR NANOTECHNOLOGIES INCORPORATED (NASDAQ: ALTI)
"Up 28.47% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ALTI.php

Altairnano is an innovator and supplier of advanced novel, ceramic nanomaterials. A seasoned management team with substantial experience in commercializing innovative, disruptive technologies, complements Altairnano's leading edge scientists. The company has developed nanomaterials for the alternative energy, life sciences and performance materials markets based on its proprietary manufacturing process. This process also provides the foundation for its innovative AHP pigment process. Altairnano is a leading manufacturer of advanced battery pack systems, which are used in stationary power applications, and electric and hybrid-electric vehicles. For more information, visit www.altairnano.com.

ALTI News:

July 8 - Altair Nanotechnologies Announces Successful Grid Interconnection and Operation of Two-Megawatt Battery System

Grid-Scale Validation Expected to Open New Markets in the Utility Sector for Altair's Battery Technology

Altair Nanotechnologies Inc. (NASDAQ: ALTI), a leading manufacturer of safe, high-performance lithium-titanate battery and energy storage products, announced the successful completion of a demonstration and validation program for a two-megawatt 500 kilowatt-hour battery system purchased by AES Corporation (NYSE: AES).

The program was developed and validated by KEMA, Inc. and executed by AES personnel and subcontractors. KEMA's testing showed the battery system successfully met the program's milestones, which was conducted to demonstrate the applicability of Altair's large platform technology to frequency regulation, a key service currently provided by power plants to the electric grid. This demonstration also suggests that the technology could be used for several other utility applications.

"The positive AES results validate the immense opportunities in the utility sector," said Terry Copeland, President and CEO for Altair Nanotechnologies. "Our patented lithium titanate battery technology represents a significant advancement in frequency regulation and can provide utilities and generating companies with a valuable tool and resource in the growing challenge of grid management."

"We are pleased with the results of the Altairnano units. This two megawatt validation project is one of the final steps in our move towards commercial deployment of grid-scale energy storage," said Chris Shelton, Director of Energy Storage Development at AES. "Fast-responding, high-efficiency energy storage systems such as these will create a more resilient grid and allow for increased use of variable generating sources such as wind and solar."

The two-megawatt battery system was installed and operated at a substation owned by Indianapolis Power & Light (IPL), an AES company. The system contained two one-megawatt battery storage units each consisting of one Altairnano 250 kilowatt-hour lithium titanate battery stack, AC-to-DC power conversion system, HVAC units, a control system and transformers to connect to the IPL grid. During the validation exercise the capacity of each unit was tested by repeatedly charging and discharging at one megawatt for 15 minutes. In a second test, two megawatts of power from each of the units were used to show the capability of paralleling two separate systems. Additional testing included simulated frequency regulation, which involved switching the units from charge to discharge at up to one megawatt of power every four seconds for several hours. The KEMA summary report will be available on Altair's website at www.altairnano.com and on the KEMA website at www.kema.com.

In August 2007 AES Corporation and Altair Nanotechnologies announced a joint development and equipment purchase agreement. Under the terms of the agreement, the companies will develop a suite of energy storage solutions. This first solution is a modular unit designed to deliver in excess of one megawatt of power and 250 kilowatt-hours of energy per unit. Multiple units can be linked together in systems to provide both more power and more energy storage.

Altair and AES are working together toward utilization of these systems to provide more efficient management of energy quality, frequency control, and real-time energy fluctuations in milliseconds at grid level. The battery systems' extended cycle-life, high-efficiency, and power profile for the continuous delivery of pulses of plus or minus one megawatt to the grid differentiate Altair's battery storage system from other potential solutions in the marketplace.

ABOUT THE AES CORPORATION

AES is one of the world's largest global power companies, with 2007 revenues of $13.6 billion. With operations in 29 countries on five continents, AES's generation and distribution facilities have the capacity to serve 100 million people worldwide. AES's 15 regulated utilities amass annual sales of over 78,000 GWh, and their 123 generation facilities have the capacity to generate more than 43,000 megawatts. The AES global workforce of 28,000 people is committed to operational excellence and meeting the world's growing power needs. To learn more about AES, visit www.aes.com or contact AES media relations at This email address is being protected from spam bots, you need Javascript enabled to view it .


AUTHENTIDATE HOLDINGS CORPORATION (NASDAQ: ADAT)
"Up 36.36% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ADAT.php

Authentidate Holding Corp., through its subsidiaries, provides software applications and Web-based services that enable enterprises and individuals to exchange the electronic content transaction securely. Its offerings incorporate security technologies, such as electronic signing, identity management, and content authentication to electronically facilitate secure and trusted transactions. The company's products include Inscrybe Healthcare, a secure Web-based information network that enables users in the healthcare industry to exchange information via the Web or fax; and Inscrybe Office, a Web-based service, which enables to sign, seal, and confirm receipt of important documents over the Web. It also provides signature-based business process software applications and solutions. In addition, Authentidate Holding Corp. is developing Inscrybe platform that incorporates the use of the U.S. Postal Service Electronic Postmark. The company sells its software and Web-based services primarily through direct sales and resellers. It operates in the United States and Germany. The company was founded in 1985 as Bitwise Designs, Inc. and changed its name to Authentidate Holding Corp. in 2001. Authentidate Holding Corp. is headquartered in Berkeley Heights, New Jersey.

ADAT News:

July 8 - ExpressMD™ Signs Non-Exclusive Distribution Agreement with Cyntrist to Deliver Remote Patient Monitoring and Telehealth Systems to Healthcare Providers in the Southeastern U.S.

Cyntrist to Utilize ExpressMD Solutions' Telehealth System to Improve Diabetic Care

ExpressMD Solutions, a joint venture formed by Authentidate Holding Corp. (NASDAQ: ADAT) and EncounterCare Solutions, Inc. (OTC: ESCL) to provide remote patient monitoring telehealth systems and services that improve care for patients, has signed its first user contract and distribution agreement with Cyntrist, a comprehensive diabetic care company headquartered in Central Florida. Cyntrist will distribute Express MD's systems and services throughout the Southeastern U.S. region. Initially Cyntrist will target Alabama, Florida, Georgia, North Carolina, and South Carolina.

ExpressMD Solutions' systems and services enable unattended measurement of a patient's vital signs and related health information. This patient data is securely sent over the Internet to the patient's healthcare provider for review.

Cyntrist will utilize ExpressMD's remote patient monitoring systems and telehealth services to monitor patients diagnosed with Diabetes. Patients will be able to use Electronic House Call(TM) equipped monitoring devices located in their home to record personal health data, including glucose levels and weight. ExpressMD Solutions' service will transmit the data to each patient's care provider as it is collected. By remotely receiving patient data daily, care providers can adjust treatment accordingly and provide an enhanced level of care. In addition, ExpressMD's solution reduces the need for regular office visits, reducing the cost of care.

"Cyntrist's decision to incorporate ExpressMD Solutions' remote patient monitoring telehealth system and services as part of its patient care capabilities, underscores the benefits that telehealth monitoring systems offer patients and healthcare providers," said Ronald Mills, Managing Director at ExpressMD Solutions. "As a way to improve patient care and reduce costs, telehealth systems have the power to change the landscape of patient monitoring. We believe our solution is ahead of the curve in this market and will be widely accepted by meeting a number of monitoring applications going forward."

In June 2008 the Centers for Disease Control and Prevention (CDC) reported that nearly 24 million Americans have diabetes (8% of the population), an increase of more than three million in approximately two years.

"By combining our world-class proprietary Diabetes information management system, Enhanced Diabetes Information System (EDIS(TM)), with ExpressMD Solutions' remote patient monitoring telehealth system, we are introducing a capability that goes above and beyond what is currently available for treating patients with Diabetes. A core advantage of this system is that it is easy for patients to use and is cost effective compared to monitoring patients multiple times per week in person. This is a very exciting opportunity for patients, providers and heath insurers," said Rogers Kirven, President of Cyntrist.

ABOUT EXPRESSMD SOLUTIONS

ExpressMD(TM) Solutions is a joint venture formed by Authentidate Holding Corp. (Nasdaq: ADAT - News) and EncounterCare Solutions, Inc. (OTC PK: ECSL). ExpressMD combines EncounterCare's Electronic House Call(TM) patient vital signs monitoring appliances with a specially designed web-based management and monitoring software module based on Authentidate's Inscrybe(TM) Healthcare platform. The company will provide in-home patient vital signs monitoring systems and services to improve care for patients with chronic illnesses and reduce cost of care by delivering results to their healthcare providers securely via the Internet. The ExpressMD solution is designed to aid wellness and preventative care, and deliver better continuity of care to specific patient segments such as the elderly, special needs or pediatric patients with chronic illnesses who require regular monitoring of serious medical conditions. For more information about ExpressMD Solutions, visit www.expressmdsolutions.com.

ABOUT CYNTRIST

Cyntrist is a comprehensive diabetes care company, headquartered in Altamonte Springs, Florida, whose "patient-centric" focus encourages, enables and supports the patient using a "Diabetes Team" approach to achieve improved health outcomes through its proprietary Enhanced Diabetes Information System (EDIS(TM)). Cyntrist's Enhanced Care Programs are targeted to anyone with diabetes who is motivated, or can be motivated, to develop improved self-care skills, and to those who support the person with diabetes. For more information about Cyntrist, visit www.cyntrist.com.

ABOUT ENCOUNTERCARE SOLUTIONS, INC.

EncounterCare Solutions, Inc. (OTC PK: ECSL), headquartered in Palm Beach Gardens, Florida is an integrated healthcare company that operates its business through two divisions, the Healthcare Technology Division and the Healthcare Services Division. EncounterCare's operating businesses offer a broad range of proprietary healthcare technology, products and services that address several substantial target markets, including: the Healthcare Information Technology market, the Healthcare Telemedicine market and the Homecare market. For more information, visit www.encountercare.com.

 
< Prev   Next >
Clicky Web Analytics